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Introduction Introduction Introduction Introduction Introduction
The placenta, a complex organ of limited life-span whose metabolic and endocrine activities are not yet fully understood, is the organ responsible for the transfer of nutrients and waste products between the fetal and maternal circulations. The placenta must integrate signals from the fetus and the mother in an attempt to match fetal demand with maternal substrate supply [1] . Therefore, it plays a pivotal role in fetal growth. The failure of placental growth and development during early and middle stages of pregnancy is directly associated with decreased fetal growth in late pregnancy [2] . Rat placenta is composed of two main regions, the junctional zone (JZ) and the labyrinthine zone (LZ). The LZ is located at the fetal interface and 326 326 326 326 326 ET Korgun et www.fhc.viamedica.pl comprises stem cells capable either of differentiating into trophoblast giant cells, or of fusing to form syncytial trophoblast cells. Labyrinthine trophoblast giant cells possess a restricted capacity for hormone production [3] , whereas syncytial trophoblast cells mediate the transfer of nutrients and wastes between maternal and fetal compartments [4] . The JZ represents the interface between the maternal and fetal tissues, and is the site of trophoblast proliferation. The LZ of the trophoblast consists of three morphologically distinct cell types: trophoblast giant cells, spongiotrophoblast cells, and glycogen cells [5] .
Trophoblast giant cells arise by endoreduplication, are situated at the maternal/placental interface, and are one of the major endocrine cells of the placenta [3] . They synthesize and secrete steroid and peptide hormones. Spongiotrophoblast cells are located immediately beneath the trophoblast giant cell layer, and synthesize and secrete peptide hormones. Glycogen cells are a transient cell type embedded among the spongiotrophoblast cells. Beyond their accumulation of glycogen, their biology is not well understood [3] .
Glucose, a primary energy substrate for fetal and placental development, is the principal carbohydrate to be transported by the placenta. It is transferred across the placenta by sodium-independent facilitated diffusion along a concentration gradient [6, 7] . In general, a family of transporter proteins mediates this process. These glucose transporters (GLUTs) are characterized by the presence of 12 membrane-spanning helices and several conserved sequence motifs. Twelve different facilitative glucose or fructose transporter isoforms, GLUT 1-GLUT 12, have been cloned [8] . GLUT proteins show a tissuespecific distribution. The predominant form expressed in the placenta during early pregnancy is GLUT 1, the tissue-barrier isoform seen in trophoblastic cell plasma membranes [9, 10] .
On the other hand, the placenta is a glucocorticoid target organ per se, with placental growth [11, 12] and endocrine function known to be affected by GCs [13] . Glucocorticoid hormone action within the cell is regulated by expression of the GR and isoforms of 11b-hydroxysteroid dehydrogenase1 and 2 (11b HSD1 and 11b HSD2) [14] [15] [16] . Therefore, many classical effects of GCs are mediated by GR [14] . Fetal GCs are derived from the mother and are present in low concentrations until the end of gestation. The transplacental GCs concentration gradient is maintained by placental 11b HSD2, which converts the active GCs, cortisol and corticosterone, to their inactive metabolites [17] . Consequently, precise control of the transplacental transfer of maternal glucocorticoids to the fetus is critical for placental and fetal development. GCs could potentially affect a wide range of cellular functions within the embryo and placenta, from trophoblast differentiation soon after implantation, to hormone synthesis in the fully differentiated placenta [18] .
Additionally, GCs specifically inhibit glucose transport in a variety of peripheral tissues, such as skeletal muscle, adipocytes, and endothelial cells [19] [20] [21] . Furthermore, placental glucose transporters expressions are regulated by GCs [22] .
Maternal diabetes is one of the commonest complications during pregnancy. The altered metabolic environment in maternal diabetes during pregnancy interferes with normal placental and fetal development. In humans, as well as in rodents, there is an increased incidence of congenital malformations and fetal growth retardation. The exposure of the placenta to a diabetic environment may lead to functional and structural derangements, including villous immaturity, enlargement of the surface area of exchange and thickening of the basement membrane [1] .
In short, inadequate transfer of compounds between mother and fetus can cause abnormalities in the developing fetus. This means that studies during placentation in diabetic rats are of great importance. It is hypothesized that GCs regulate placental glucose transport in many cell types and tissues. Therefore, the aim of this study was to investigate the relationship between glucose transport and the glucocorticoid metabolism in rat placental development of normal and diabetic pregnancy, focusing on the GR and GLUT 1 protein. nimals. nimals. Female albino rats (Rattus norvegicus) (250-270 g) were kept at a temperature of 22 ± 2°C and maintained on a cycle of 12 hours light/12 hours darkness, with free access to food and water. The rats had been kept in cages, as with two female per one male rat. The onset of pregnancy was determined by vaginal smear inspection to see spermatozoa after overnight mating. The day when a positive smear was found was designated day 0 of pregnancy. Diabetes mellitus was experimentally induced by a single intraperitoneal (i.p.) injection of 60 mg/kg body weight streptozotocin (STZ, Sigma Chemical Co. S 0130) 50 mM sodium citrate buffer, pH 4.5 on day six of gestation. Control rats received an equal volume of citrate buffer. After two days of STZ injection, diabetes was confirmed when blood glucose concentration was measured to be greater than 250 mg/dl. On days 13, 15, 17, 19 and 21 of pregnancy, rats were anesthetized with ether. The experimental design and number of animals, placentas and embryos is shown in Table 1 . The anterior abdominal wall was opened and placentas and fetuses were collected and rapidly weighed. Some of the 327 327 327 327 327
Material and methods
Expression of GR and GL Expression of GR and GL Expression of GR and GL Expression of GR and GL Expression of GR and GLUT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta The paraffin-embedded serial sections (6 mm) were collected on SuperFrost Plus slides (Novoglas, Berne, Switzerland). After re-hydration, samples were transferred to 0.01 M citrate buffer (pH = 6) and subsequently heated in a microwave oven for 2 × 5 minutes at 750 W for antigen-retrieving. After cooling for 20 minutes at room temperature, the sections were washed with PBS. To remove endogenous peroxidase activity, sections were kept in 3% H 2 O 2 for 20 minutes, and afterwards washed with PBS. Sections were incubated for 60 minutes at room temperature in a moist chamber with two rabbit antisera one against to C-terminal sequences of GLUT 1 (AB 1340 from Chemicon, Temecula, CA, USA) and the other two N-terminal sequences of GR (Sc-1004 from Santa Cruz Biotechnology, Santa Cruz, CA, USA). Antisera were diluted 1:1,000 (GR), and 1:2,000 (GLUT 1) with Antibody Diluent (Dako, Carpinteria, CA, USA). Labeling was visualized using the Universal LSAB 2 Kits (Dako, K 0609) according to the instructions of the manufacturer. The sections were counterstained with Mayers's hemalum (Merck, Darmstadt, Germany) and mounted with Kaiser's glycerol gelatin (Merck). For controls, sections were incubated with rabbit serum (Dako X 0902). Photographs were taken with an Axiophot microscope (Zeiss, Oberkochen, Germany).
Investigations were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research of the National Academy of Science, Bethesda, MD, USA, 1996). SDS-polyacrylamide gel electrophoresis and W SDS-polyacrylamide gel electrophoresis and W SDS-polyacrylamide gel electrophoresis and W SDS-polyacrylamide gel electrophoresis and W SDS-polyacrylamide gel electrophoresis and Western estern estern estern estern blotting. blotting. blotting. blotting. blotting. Cellular proteins from diabetic and control rat placenta were solubilized in Laemmli sample buffer (Sigma) supplemented with Complete R protease inhibitor cocktail (Boehringer, Mannheim, Germany). Insoluble material was removed by centrifugation at 100,000 × g for 1 hour at 4°C. Samples were stored at -70°C. Prior to electrophoresis, samples were boiled for three minutes at 100°C. T T T T Table 1 Amounts of protein were determined according to Lowry et al. [23] and 50 μg protein was applied to each lane. Samples were subjected to SDS-polyacrylamide gel electrophoresis on 8-18% gradient gels (ExcelGel; Pharmacia, Uppsala, Sweden) using SDS buffer strips (ExcelGel, Pharmacia). Samples were run for 150 minutes at a constant 600 V/50 mA/30 W. Proteins were transferred onto nitrocellulose membranes (Pharmacia) by semi-dry electroblotting in a buffer containing 0.2 mol/l glycine, 25 mM Tris and 20% methanol for 45 minutes at 30 V/100 mA/6 W. Successful transfer was confirmed by Ponceau S (Sigma) staining of the blots. The membranes were blocked for 1 hour with 5% non-fat dry milk (Bio--Rad, Hercules, CA, USA) and 0.1% Tween-20 (Sigma) in 0.14 mol/l Tris-buffered saline (TBS) pH 7.2-7.4 at 4°C. The same solution was used for subsequent washing steps and as a diluent for the antibodies. The blotting membranes were incubated overnight at 4°C with rabbit antisera against GLUT 1 (1:3,000) and GR (1:200). After washing, the membranes were further incubated with goat anti-rabbit IgG horseradish peroxidase conjugate (Bio--Rad) diluted 1:2,000 for 1 hour at room temperature. After three washing steps in TBS, pH 7.2-7.4, immunolabeling was visualized using the chemiluminescencebased SuperSignal CL -HRP Substrate System (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. Membranes were exposed to Hyperfilm (Amersham), which was subsequently scanned using an Alpha Digi Doc TM densitometer and quantified with AlphaEaseFC software (Alpha Digi Doc 1000). Control blots were incubated with antibody diluent alone. Blood glucose level was routinely determined using a glucometer according to the user's guide, with certain modifications. Blood samples were collected from rat tail veins and a drop of blood was applied to the pad of the glucose strips. After 20 seconds, the pad surface was carefully blotted dry and inserted into the test slot of the glucometer. We measured the maternal glucose concentration during gestational days 13, 15, 17, 19, 21 . The data is shown in Figure 1A .
Hyperglycemia effects on placenta Hyperglycemia effects on placenta Hyperglycemia effects on placenta Hyperglycemia effects on placenta Hyperglycemia effects on placenta and body weights of fetus and body weights of fetus and body weights of fetus and body weights of fetus and body weights of fetus
The fetuses and the placentas were weighed from GD13 to GD21. The fetuses of the diabetic rat model showed intrauterine growth retardation compared to the fetuses of the control group. Significant differences were observed in fetal weight between the control and diabetic groups on GD13, GD17 and GD21 (p < 0.001 by Mann-Whitney U test) (Figure 1B) . Placental weights of diabetic mothers were During the development of the normal and diabetic rat placenta, we determined the immunocytochemical localization of GR and GLUT 1 proteins. The data from the immunohistochemistry is summarized in Table 2. The two observers were always concordant, except for the assessments of weak to moderate staining.
Chorioallantoic placenta
The chorioallantoic placenta consists of two distinct zones: the LZ, the major site of maternal fetal exchange, and the JZ, the primary site of placental steroid and peptide hormone synthesis. L L L L Localization of GR ocalization of GR ocalization of GR ocalization of GR ocalization of GR On the 13 th day of pregnancy of the normal and diabetic rat placenta, there was GR expression mainly in the LZ, but also in the JZ at particularly high levels in the trophoblast cells and endothelial cells surrounding the maternal blood vessels (Figure 2A) . Figures 2D, F) . The reaction pattern of GLUT 1 remained constant from GD15 to GD 21, with only slight changes in intensity (Table 2) .
Expression levels of GLUT 1 were increased towards the end of gestation, especially spongiotrophoblast cells of JZ and endothelial cells of the LZ in the diabetic rat placenta (Figures 3E, F) . One of the characteristic properties of diabetic placenta is numerous cysts and glycogen cells which are immunopositive for GLUT 1 ( Figure 3H ) but not GR ( Figure 3G ).
Yolk sac placenta
The yolk sac placenta is composed of parietal yolk sac and visceral yolk sac, the second site for maternal-fetal exchange. GR ( Figure 2G ) but not GLUT 1 ( Figure 2H) were detected in the fetal mesenchymal cells. Yolk sac epithelium was immunopositive for GLUT 1 ( Figure 2H ) but not GR ( Figure 2G ). GLUT 1 was not found in the parietal and visceral endodermal cells, but visceral endodermal cells were immunopositive for GR (data not shown).
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UT 1 and GR UT 1 and GR UT 1 and GR UT 1 and GR in the placenta on immunoblots in the placenta on immunoblots in the placenta on immunoblots in the placenta on immunoblots in the placenta on immunoblots GR and GLUT 1 protein expressions as quantified by Western blotting in normal and diabetic rat placentas from GD13 to GD21 are shown in Figures 4A, B . GR and GLUT 1 proteins were detected by Western blot analysis as single bands at the expected sizes of 95 and 54 kDa, respectively. Amounts of the control and diabetic placental GR and GLUT 1 proteins increased towards gestational days ( Figures 4A, B) . However, only the placental GR protein at GD17 and GD19 day was significantly increased in the STZ-diabetic rats compared to the control rats (p < 0.001, Figure 4A ).
Discussion
Discussion Discussion Discussion Discussion Our study demonstrates, for the first time, the spatial and temporal localization patterns of GR and GLUT 1 proteins in diabetic rat placenta. . . . . Glucocorticoid dynamics during diabetic pregnancy is a controversial issue. Plasma corticosterone levels at term are dependent on the severity of maternal diabetes [24] . Maternal and fetal plasma corticosterone levels of diabetic rats were significantly lower than the corresponding control values between GD19 and GD22 [25] . We detected GR expression to be significantly increased between the 17 th and 19 th days of pregnancy in diabetic rats. Van Beek et al. [26] established that GCs increase 11b-HSD2 activity and mRNA expression, but conversely decrease GR mRNA expression in cultured human trophoblast cells. Additionally, treatment of trophoblasts with the GR antagonist RU-486 blocked the glucocorticoid--induced increase of 11b-HSD2 activity, indicating that the effect of GCs on 11b-HSD2 is probably mediated by GR [26] . In this study, we failed to detect 11b-HSD2 in rat placenta during pregnancy, but a previous study showed 11b-HSD2 gene expression to be decreased in placentas of STZ-induced diabetic pregnant rats [27] . Our data demonstrating the increased levels of GR protein in the placentas of STZ-induced diabetic rats in late pregnancy may indicate that 11b-HSD2 is mediated by GR, similar to the results obtained by Van Beek et al. [26] . Our data suggests that diabetic rat placentas show increased expression towards the GR and sustain the catabolism of corticosterone.
We found that GR protein expression in endothelial cells of the LZ was associated with the maternal blood vessels; thus GR is ideally located for its proposed role in regulating the transplacental passage of maternal glucocorticoid to the fetus by the mechanism to protect the fetal compartment from high levels of maternal glucocorticoids. Expression of GR protein was detected in both labyrinthic and junctional layers of rat placenta, indicating these two important sites are glucocorticoid target sites. Therefore, the co-expression of GLUT 1 with GR protein in trophoblast cells of the LZ and in the spongiotrophoblast cells of the JZ may suggest that GR activity might participate in regulating local glucocorticoid-mediated cellular differentiation, placental growth and function, such as expressions of glucose transporters proteins.
GR was abundantly expressed in the spongiotrophoblast and giant cells of the JZ. Therefore, GCs may regulate placental synthesis of both steroid and 
This table was designed according to the percentage of positively stained cell count; 3, 2, 1, and 0 indicate the differences in signal intensities observed by optical microscopy and reflect levels of GR and GLUT 1 proteins: 0 = absent; 1 = weak expression (10-30%); 2 = moderate expression (40-60%); and 3 = high expression (70-100% www.fhc.viamedica.pl peptide hormones. During diabetes, several metabolic adjustments take place to tailor high circulating blood glucose levels. Glucocorticoid and GR might play a critical role in such metabolic conditions. In various tissues, GCs down-regulate glucose transport systems; however, their action on glucose transport systems in placenta is unknown, especially in the diabetic placenta. Previous studies found that, in rats treated with GCs from day 15 to day 21 of pregnancy, placental GLUT 1 and GLUT 3 protein expressions increased dose-dependently. Increased Figure 3 . Figure 3 . Figure 3 . Figure 3 . Values are expressed as mean ± SEM of ratio of control GD13 GLUT 1 levels. Statistically significant effects of GLUT 1 expression in the diabetic rat placenta are not indicated placental GLUT 1 and GLUT 3 protein expressions may reflect an attempt to increase placental or fetal glucose supply to attenuate the effect of excessive exposure to GCs in diminishing fetal growth [28] . In contrast, both GLUT 1 and GLUT 3 transcripts and proteins were significantly downregulated in isolated human trophoblast cells and in rat placentas by exposure to GCs [22] . The results of previous studies show that expressions of GLUT 1 and GLUT 3 proteins in the rat placenta are differentially affected by GC treatment. Our result regarding the protein levels of GR and GLUT 1 showed that the glucose transport system was working independently from GR protein expression in normal and diabetic placenta. However, both GR and GLUT 1 proteins were expressed in spongiotrophoblast cells, endothelial cells and trophoblast cells at the same time. So, there may also be an autocrine regulation between GR and GLUT 1.
Ogura et al. [29] demonstrated that GLUT 1 protein in placentas from diabetic mice was significantly decreased compared to controls. In spite of this, we determined that the expression level of GLUT 1 protein was not different in the developing normal rat placenta compared to diabetic placenta. Other reports have found no significant change in rat placental GLUT 1 protein levels after STZ [30, 31] and glucose [32] treatment, mirroring our data. Conversely, GLUT 3 mRNA and protein expressions in diabetic rat placentas increased compared to controls [30, 31] . Our immunohistochemical results showed that GLUT 1 protein was localized mainly in the membranes on both sides of the trophoblast cells that predominantly line the labyrinthine maternal vascular spaces, and abundantly in the fetal endothelial cells. These findings suggest that GLUT 1 expression in the rat placenta is specifically localized in cells responsible for transplacental glucose transport. On the other hand, we showed for the first time that there is a higher expression of GLUT 1 in the glycogen cells in early pregnancy compared to late pregnancy. This phenomenon may protect fetuses from glucose toxicity and deposit glucose as glycogen, an energy resource for placental development.
The placental weights of STZ induced diabetic rats at term are higher than those of control animals [33] . By contrast, the weight and nucleic acid content of diabetic rat placenta on days 14 and 16 of gestation are significantly lower [34] . We found placental weights of diabetic mothers were significantly lower on GD15 and higher on GD17 and GD21 (p < 0.001 by Mann-Whitney U test) than placental weights from control rats ( Figure 1C ). Our data supported the previous studies and suggests that perhaps glucose inhibits proliferation in the diabetic placental cells in the early gestational stage, and as a result placental growth diminished. The proliferative activity of diabetic placental cells was found to be high on GD17 and GD21.
The fetuses of our diabetic model showed intrauterine growth retardation compared to fetuses of the control group. These observations showed that placental GLUT 1 protein expression could not be stimulated under hyperglycemic conditions. Thus, perhaps another glucose transporter isoform, such as GLUT 3, may play a pivotal role in the severe alterations of placental function observed in diabetic pregnancies.
Our findings indicated that STZ-induced diabetes increased the activation of placental GR in late 333 333 333 333 333
Expression of GR and GL Expression of GR and GL Expression of GR and GL Expression of GR and GL Expression of GR and GLUT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta UT 1 in the diabetic rat placenta www.fhc.viamedica.pl pregnancy that might influence the differentiation process via GCs in placenta. The precise mechanisms of GR regulation in STZ-induced diabetes are, however, unclear. Moreover, it will be of much clinical significance, in future, to unravel the correlation between STZ-induced diabetes and the regulation of GR function. Further investigation is necessary to clarify the role of GR in the diabetic rat placental glucose transport mechanism.
In conclusion, the localization pattern of GR and GLUT 1 proteins in the same cell types led us to believe that there might be a relationship between GR and GLUT 1 expressions at the cellular level. GLUT 1 does not play a pivotal role in diabetic pregnancies. However, placental growth abnormalities during diabetic pregnancy may be related to the amount of GR.
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